The expression levels of GLRX3 in pancreatic cancer were 8.8-fold greater than those in control plasma (p < 0.001) and 2.8-fold greater than those in chronic pancreatitis (p = 0.005). Here, GLRX3 is linked to pancreatic neoplasm.